secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001628280-25-031311
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics raises ~$1.9M net in $0.30/share public offering for clinical studies
--------------------------------------------------------------------------------

- Gross proceeds $2,002,500 from 6,675,000 shares at $0.30/share; underwriter exercised over-allotment for 1,001,250 additional shares.
- Net proceeds ~$1.9M after underwriting discounts and expenses; offering closed June 13, 2025.
- Representative's Warrants for 383,812 shares (5% of offering) issued at $0.375 exercise price, 5-year term.
- Proceeds to fund INVINCIBLE-4 data readout (expected H1 2026) and continue INVINCIBLE-3 study maintenance.
- ThinkEquity acted as sole book-running manager; shares traded on Nasdaq under INTS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/0001628280-25-031311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/intensity-20250611.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-031311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer